Literature DB >> 9634853

Testis-derived Sertoli cells survive and provide localized immunoprotection for xenografts in rat brain.

P R Sanberg1, C V Borlongan, S Saporta, D F Cameron.   

Abstract

Transplantation of neural tissue into the mammalian central nervous system has become an alternative treatment for neurodegenerative disorders such as Parkinson's disease. Logistical and ethical problems in the clinical use of human fetal neural grafts as a source of dopamine for Parkinson's disease patients has hastened a search for successful ways to use animal dopaminergic cells for human transplantation. The present study demonstrates that transplanted testis-derived Sertoli cells into adult rat brains survive. Furthermore, when cotransplanted with bovine adrenal chromaffin cells (xenograft), Sertoli cells produce localized immunoprotection, suppress microglial response and allow the bovine cells to survive in the rat brain without continuous systemic immunosuppressive drugs. These novel features support Sertoli cells as a viable graft source for facilitating the use of xenotransplantation for Parkinson's disease and suggest their use as facilitators, (i.e., localized immunosuppression) for cell transplantation in general.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9634853     DOI: 10.1038/nbt1296-1692

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  35 in total

1.  Expansion of mouse sertoli cells on microcarriers.

Authors:  B Shi; S Zhang; Y Wang; Y Zhuang; J Chu; S Zhang; X Shi; J Bi; M Guo
Journal:  Cell Prolif       Date:  2010-06       Impact factor: 6.831

2.  The "Glow"rious Sertoli and germ cells: mouse testis development visualized in multi-colors.

Authors:  T Rajendra Kumar
Journal:  Biol Reprod       Date:  2010-10-20       Impact factor: 4.285

Review 3.  Challenges and emerging technologies in the immunoisolation of cells and tissues.

Authors:  John T Wilson; Elliot L Chaikof
Journal:  Adv Drug Deliv Rev       Date:  2007-10-11       Impact factor: 15.470

4.  Comparative effect of human platelet derivatives on proliferation and osteogenic differentiation of menstrual blood-derived stem cells.

Authors:  Somaieh Kazemnejad; Roghaieh Najafi; Amir Hassan Zarnani; Saman Eghtesad
Journal:  Mol Biotechnol       Date:  2014-03       Impact factor: 2.695

5.  Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.

Authors:  Hongyun Huang; Lin Chen; Paul Sanberg
Journal:  Cell Med       Date:  2010-01-01

6.  Application of a Fas ligand encoding a recombinant adenovirus vector for prolongation of transgene expression.

Authors:  H G Zhang; G Bilbao; T Zhou; J L Contreras; J Gómez-Navarro; M Feng; I Saito; J D Mountz; D T Curiel
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

Review 7.  Testicular defense systems: immune privilege and innate immunity.

Authors:  Shutao Zhao; Weiwei Zhu; Shepu Xue; Daishu Han
Journal:  Cell Mol Immunol       Date:  2014-06-23       Impact factor: 11.530

8.  Characterization and functionality of proliferative human Sertoli cells.

Authors:  Kitty Chui; Alpa Trivedi; C Yan Cheng; Diana B Cherbavaz; Paul F Dazin; Ai Lam Thu Huynh; James B Mitchell; Gabriel A Rabinovich; Linda J Noble-Haeusslein; Constance M John
Journal:  Cell Transplant       Date:  2010-11-05       Impact factor: 4.064

9.  Therapeutic Potential of Pretreatment with Allograft Sertoli Cells Transplantation in Brain Ischemia by Improving Oxidative Defenses.

Authors:  Sara Milanizadeh; Karrar Najm Najaf Zuwarali; Abbas Aliaghaei; Mohammad Reza Bigdeli
Journal:  J Mol Neurosci       Date:  2018-03-17       Impact factor: 3.444

10.  Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone.

Authors:  Francesca Fallarino; Giovanni Luca; Mario Calvitti; Francesca Mancuso; Claudio Nastruzzi; Maria C Fioretti; Ursula Grohmann; Ennio Becchetti; Anne Burgevin; Roland Kratzer; Peter van Endert; Louis Boon; Paolo Puccetti; Riccardo Calafiore
Journal:  J Exp Med       Date:  2009-10-12       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.